End of Study Activities

End of study for a subject is determined as either completion of the final study visit at the end of the post-procedure phase as per protocol, or completion of an earlier visit due to a subject’s early voluntary withdrawal or early investigator termination.

END OF STUDY FORM
The END OF STUDY case report form will be completed at the time of the subject’s final study visit. The END OF STUDY form will document if the subject completed the entire study as per protocol, or the date and reason for early termination.

EARLY STUDY TERMINATION FORM
The EARLY STUDY TERMINATION case report form will be completed if the subject’s final study visit is the not the study final visit. The EARLY STUDY TERMINATION form will document the date of early termination, the last study visit/action completed, whether the early termination was initiated by the subject or the Principal Investigator, and the reason for the early termination.

• Exit Physical Examination, as per the study qualification evaluation.
• Exit Neurological Examination, as per the study qualification evaluation.

The Schedule of Study Activities that outlines all of the subject activities from study entry to completion is contained in Appendix E.

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

Copyright © 2009 by Pico-Tesla. All rights reserved
Sitemap | Privacy Policy & Terms of Use

Website design by DDA Medical

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical^®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.

About Us | Our Team | Participate In Our Research | News Releases | Terms & Conditions of Use
Patients & Caregivers | Physicians & Medical Providers | Research & Publications | Press Kit & News | FDA Approval Status
The Device Overview | The Device | User Interface | Safety and Risks | FDA Clearance
Neuromodulation & Electromagnetics Overview | The Resonator™ Device Compared to MRI | The Resonator™ Device Versus TMS and rTMS
The Resonator™ Device Compared to Other Parkinson's Disease Therapies | Theory of Mechanism Overview | Jacobson Resonance™
Parkinson's Disease Study | Alzheimer's Disease Study | Fibromyalgia Disease Study | Osteoarthritis Disease Study
Pico-Tesla’s Resonator™ Magnetic Therapy Device | Resonator™ Magnetic Therapy Device | A Complementary and Alternative Medicine
Complementary and Alternative Therapy | Magnetic Resonance Therapy | Conditions Treated with Magnetic Therapy
Other Forms of Deep Brain Stimulation

Pico-Tesla Magnetic Therapies are holding clinical trials for Parkinson’s patients. They are testing to see if the new Resonator® device, using pulsed magnetic field therapy, is successful in improving the quality of life for people living with Parkinson’s disease. Those who qualify for these clinical trials will be compensated.

Currently, these clinical trials are being held in Novi, Michigan and Clearwater, Florida. All locations are in close proximity to major cities in each state. Patients interested in participating can contact Pico-Tesla for more information.